Insider Trading Bull's-Eye: FDA Chemist Charged With Using Agency's DARRTS NDA Tracking System For Improper Trades
This article was originally published in The Pink Sheet Daily
Executive Summary
A criminal complaint charges Cheng Yi Liang with trading in the securities of five companies based on the status of their new drug applications, gaining more than $2 million.
You may also be interested in...
Insider Trading By Ex-FDA Official Puts Spotlight On Agency Practices
After Office of Generic Drugs Deputy Director Gordon Johnston left FDA, he joined GPhA and 'tricked' a former colleague into sharing info on generic Lovenox on behalf of a hedge fund he was secretly working for, SEC says.
Insider Trading By Ex-FDA Official Puts Spotlight On Agency Practices
After Office of Generic Drugs Deputy Director Gordon Johnston left FDA, he joined GPhA and 'tricked' a former colleague into sharing info on generic Lovenox on behalf of a hedge fund he was secretly working for, SEC says.
Insider Trading By Ex-FDA Official Puts Spotlight On Current Agency Practices
After Office of Generic Drugs Deputy Director Gordon Johnston left FDA, he joined GPhA and 'tricked' a former colleague into sharing info on generic Lovenox on behalf of a hedge fund he was secretly working for, SEC says.